V920-001

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V920-001, covering 2019-10-23 to 2019-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) [Phase 1]